Literature DB >> 25960420

The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship.

Boris Hinz1.   

Abstract

Physiological tissue repair aims at restoring the mechano-protective properties of the extracellular matrix. Consequently, redundant regulatory mechanisms are in place ensuring that tissue remodeling terminates once matrix homeostasis is re-established. If these mechanisms fail, stromal cells become continuously activated, accumulate excessive amounts of stiff matrix, and fibrosis develops. In this mini-review, I develop the hypothesis that the mechanical state of the extracellular matrix and the pro-fibrotic transforming growth factor (TGF)-β1 cooperate to regulate the remodeling activities of stromal cells. TGF-β1 is stored in the matrix as part of a large latent complex and can be activated by cell contractile force that is transmitted by integrins. Matrix straining and stiffening lower the threshold for TGF-β1 activation by increasing the mechanical resistance to cell pulling. Different elements of this mechanism can be pharmacologically targeted to interrupt the mechanical positive feedback loop of fibrosis, including specific integrins and matrix protein interactions.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Fibronectin; Fibrosis; Latency associated peptide (LAP); Latent TGF-β1 binding protein (LTBP-1); Strain

Mesh:

Substances:

Year:  2015        PMID: 25960420     DOI: 10.1016/j.matbio.2015.05.006

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  163 in total

Review 1.  Blood Brothers: Hemodynamics and Cell-Matrix Interactions in Endothelial Function.

Authors:  Arif Yurdagul; A Wayne Orr
Journal:  Antioxid Redox Signal       Date:  2016-02-19       Impact factor: 8.401

Review 2.  Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?

Authors:  Yoginee Sritharen; Maurice Enriquez-Sarano; Hartzell V Schaff; Grace Casaclang-Verzosa; Jordan D Miller
Journal:  Physiology (Bethesda)       Date:  2017-05

Review 3.  The changing role of TGFβ in healthy, ageing and osteoarthritic joints.

Authors:  Peter M van der Kraan
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

Review 4.  Extracellular matrix: The driving force of mammalian diseases.

Authors:  Renato V Iozzo; Maria A Gubbiotti
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

Review 5.  Progress in three-dimensional printing with growth factors.

Authors:  Gerry L Koons; Antonios G Mikos
Journal:  J Control Release       Date:  2018-12-20       Impact factor: 9.776

6.  Identification of the growth factor-binding sequence in the extracellular matrix protein MAGP-1.

Authors:  Thomas J Broekelmann; Nicholas K Bodmer; Robert P Mecham
Journal:  J Biol Chem       Date:  2020-01-27       Impact factor: 5.157

Review 7.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

Review 8.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

9.  Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation.

Authors:  Ming Kong; Junmin Lee; Iman K Yazdi; Amir K Miri; Yi-Dong Lin; Jungmok Seo; Yu Shrike Zhang; Ali Khademhosseini; Su Ryon Shin
Journal:  Adv Healthc Mater       Date:  2019-01-04       Impact factor: 9.933

Review 10.  Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions.

Authors:  Maria A Gubbiotti; Sylvain D Vallet; Sylvie Ricard-Blum; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-30       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.